This virtual study day will focus on the recent advances seen within myeloma, chronic lymphocytic leukemia, lymphoma, rare and atypical myeloproliferations, myeloid and genomics and how diagnostic advances guide the individual patient pathway.
- Myeloid & Genomics
- Rare and Atypical Myeloproliferations
The full programme and further details are now available on the meeting website – https://hartleytaylor.co.uk/hmd3-home/
Registration is Free of Charge – click here to register – https://hartleytaylor.co.uk/hmd3-registration/